BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3918314)

  • 1. HLA class-II immune response genes and products in leprosy.
    de Vries RR; van Eden W; Ottenhoff TH
    Prog Allergy; 1985; 36():95-113. PubMed ID: 3918314
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3.
    van Eden W; Elferink BG; de Vries RR; Leiker DL; van Rood JJ
    Clin Exp Immunol; 1984 Jan; 55(1):140-8. PubMed ID: 6362932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occasional review--HLA and leprosy: a re-evaluation.
    van Eden W; de Vries RR
    Lepr Rev; 1984 Jun; 55(2):89-104. PubMed ID: 6431213
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
    Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
    J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of immunopathology induced by Mycobacterium leprae.
    de Vries RR
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):12-6. PubMed ID: 1904200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II immune response and suppression genes in leprosy.
    Ottenhoff TH; de Vries RR
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):521-34. PubMed ID: 3116126
    [No Abstract]   [Full Text] [Related]  

  • 8. [The genetic susceptibility to leprosy in humans].
    Lagrange PH; Abel L
    Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of T cell responsiveness against mycobacterial antigens by HLA class 2 immune response genes.
    de Vries RR
    Rev Infect Dis; 1989; 11 Suppl 2():S400-3. PubMed ID: 2496455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae.
    Samuel NM; Mirsky R; Grange JM; Jessen KR
    Clin Exp Immunol; 1987 Jun; 68(3):500-9. PubMed ID: 3115648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-linked control of predisposition to lepromatous leprosy.
    van Eden W; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
    J Infect Dis; 1985 Jan; 151(1):9-14. PubMed ID: 3880800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to leprosy. II. Genetic control of murine T cell proliferative responses to Mycobacterium leprae.
    Douglas-Jones AG; Watson JD
    J Immunol; 1985 Oct; 135(4):2824-8. PubMed ID: 3928757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
    Thole JE; Janson AA; Cornelisse Y; Schreuder GM; Wieles B; Naafs B; de Vries RR; Ottenhoff TH
    J Immunol; 1999 Jun; 162(11):6912-8. PubMed ID: 10352313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro lymphocyte stimulation in an approach to study the expression of HLA-encoded genes predisposing to tuberculoid leprosy.
    van Eden W; Elferink D
    Int J Lepr Other Mycobact Dis; 1983 Mar; 51(1):110-2. PubMed ID: 6408015
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-helper cell subpopulations and the immune spectrum of leprosy.
    Ramos T; Zalcberg-Quintana I; Appelberg R; Sarno EN; Silva MT
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):73-81. PubMed ID: 2525166
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
    Nath I; Van Rood JJ; Mehra NK; Vaidya MC
    Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of leprosy. New developments.
    Ottenhoff TH
    Trop Geogr Med; 1994; 46(2):72-80. PubMed ID: 8079394
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.